标题
Discovery and development of surotomycin for the treatment of Clostridium difficile
作者
关键词
<em class=EmphasisTypeItalic >Clostridium difficile</em>, Diarrhea, Gastrointestinal, Surotomycin, Vancomycin
出版物
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
Volume 43, Issue 2-3, Pages 195-204
出版商
Springer Nature
发表日期
2015-12-15
DOI
10.1007/s10295-015-1714-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations Associated with Reduced Surotomycin Susceptibility in Clostridium difficile and Enterococcus Species
- (2015) Hannah M. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile
- (2015) Mohammed Zahidul Alam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Surotomycin on Clostridium difficile Viability and Toxin ProductionIn Vitro
- (2015) Laurent Bouillaut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Practice Parameters for the Management of Clostridium difficile Infection
- (2015) Scott R. Steele et al. DISEASES OF THE COLON & RECTUM
- Spore Cortex Hydrolysis Precedes Dipicolinic Acid Release during Clostridium difficile Spore Germination
- (2015) Michael B. Francis et al. JOURNAL OF BACTERIOLOGY
- Structure–Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea
- (2015) Ning Yin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
- (2015) Angie M. Jarrad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surotomycin Demonstrates LowIn VitroFrequency of Resistance and Rapid Bactericidal Activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium
- (2014) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection
- (2014) C. H. Chilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections
- (2013) Christina M Surawicz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clostridium difficile 027/BI/NAP1 Encodes a Hypertoxic and Antigenically Variable Form of TcdB
- (2013) Jordi M. Lanis et al. PLoS Pathogens
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
- (2012) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
- (2012) Scott G. Franzblau et al. TUBERCULOSIS
- Inactivation of the Lipopeptide Antibiotic Daptomycin by Hydrolytic Mechanisms
- (2011) Vanessa M. D'Costa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
- (2010) Barry I. Eisenstein et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production
- (2010) M. Merrigan et al. JOURNAL OF BACTERIOLOGY
- Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
- (2010) Julian G. Hurdle et al. NATURE REVIEWS MICROBIOLOGY
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
- (2009) Stuart Johnson JOURNAL OF INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now